Novo Nordisks semaglutide (Ozempic for diabetes, Wegovy for obesity) and Eli Lillys dual-agonist tirzepatide (Mounjaro, a related drug that also activates the GIP hormone receptor) have become blockbusters , propelling their companies to record-high market valuations ( [15] ) ( [16] )
However, during hyperactive glucose metabolism, pyruvate can be atypically metabolized into free acetate instead of acetyl-CoA [59]
[137] Days later, the company announced it would acquire Aurora kinase A inhibitor developer AurKa Pharma, and control over the lead compound, AK-01, for up to $575 million
Prenatal exposure to phthalate esters and PAHs and birth outcomes
Dark Spot & Discoloration Care: Fade stubborn dark spots and hyperpigmentation on both the face and body